Takeaway
Heterogeneity exists in the characteristics and seeding abilities of α-synuclein in dementia with Lewy bodies (DLB) and Parkinson’s disease (PD) with dementia, potentially influencing treatment development.
Why this matters
It is not clear whether the synucleinopathies DLB and PD with dementia are different diseases or variants of the same disease spectrum.